Local Treatment, Radical Cystectomy, and Urinary Diversion

  • Daniel Phat Nguyen
  • George Niklaus ThalmannEmail author
Living reference work entry


The open technique of radical cystectomy (RC) has become an efficacious and safe procedure for patients with muscle-invasive or high-risk non-muscle-invasive bladder cancer. Disease-free survival probabilities range from 60% to 70% at 5 years and from 50% to 65% at 10 years. In recent years, more focus has been placed on quality of life after RC. There is evidence that nerve-sparing techniques have a beneficial effect on short- and long-term continence rates in patients with continent urinary diversion. Furthermore, advances in robotic surgery have turned robot-assisted RC (RARC) into a potential alternative to the open procedure. While RARC has not shown benefit in terms of complication outcomes or perioperative morbidity, short-term oncologic data for RARC appear acceptable (bearing in mind that selection bias in most series precludes definitive conclusions). There is general consensus, however, that pelvic lymph node dissection (PLND) should be performed in every case of RC. From observational data, a more extensive PLND template is associated with higher detection rate of lymph node metastasis and lower adjusted risk of mortality. The results of two prospective, randomized trials comparing extended and standard templates are highly anticipated. Following RC, urinary diversion is mandatory. Ileal conduits are most commonly performed, while continent cutaneous urinary diversions represent a valid alternative. Orthotopic bladder substitution allows preservation of an intact body image and normal voiding function and thus of a normal lifestyle, though it requires careful patient selection, meticulous surgical technique, conscientious postoperative patient instruction, and lifelong follow-up.


  1. Abdi H, Pourmalek F, Gleave ME, So AI, Black PC. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy. World J Urol. 2016;34(1):41–8. Scholar
  2. Abdollah F, Sun M, Schmitges J, Djahangirian O, Tian Z, Jeldres C, et al. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy. BJU Int. 2012;109(8):1147–54. Scholar
  3. Abol-Enein H, Tilki D, Mosbah A, El-Baz M, Shokeir A, Nabeeh A, et al. Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study. Eur Urol. 2011;60(3):572–7. Scholar
  4. Advanced Bladder Cancer Meta-Analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data. Eur Urol. 2005;48(2):202–6. Scholar
  5. Albisinni S, Fossion L, Oderda M, Aboumarzouk OM, Aoun F, Tokas T, et al. Critical analysis of early recurrence after laparoscopic radical cystectomy in a large cohort by the ESUT. J Urol. 2016;195(6):1710–6. Scholar
  6. Alsaid B, Karam I, Bessede T, Abdlsamad I, Uhl JF, Delmas V, et al. Tridimensional computer-assisted anatomic dissection of posterolateral prostatic neurovascular bundles. Eur Urol. 2010;58(2):281–7. Scholar
  7. Alsaid B, Bessede T, Diallo D, Moszkowicz D, Karam I, Benoit G, et al. Division of autonomic nerves within the neurovascular bundles distally into corpora cavernosa and corpus spongiosum components: immunohistochemical confirmation with three-dimensional reconstruction. Eur Urol. 2011;59(6):902–9. Scholar
  8. Bochner BH, Dalbagni G, Sjoberg DD, Silberstein J, Keren Paz GE, Donat SM, et al. Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial. Eur Urol. 2015;67(6):1042–50. Scholar
  9. Boström PJ, Kössi J, Laato M, Nurmi M. Risk factors for mortality and morbidity related to radical cystectomy. BJU Int. 2009;103(2):191–6. Scholar
  10. Bruins HM, Arends TJH, Pelkman M, Hulsbergen-van de Kaa CA, van der Heijden AG, Witjes JA. Radical cystectomy in a Dutch University hospital: long-term outcomes and prognostic factors in a homogeneous surgery-only series. Clin Genitourin Cancer 2014;12(3):190–5.
  11. Burkhard FC, Kessler TM, Fleischmann A, Thalmann GN, Schumacher M, Studer UE. Nerve sparing open radical retropubic prostatectomy – does it have an impact on urinary continence? J Urol. 2006;176(1):189–95. Scholar
  12. Catarin MV, Manzano GM, Nóbrega JA, Almeida FG, Srougi M, Bruschini H. The role of membranous urethral afferent autonomic innervation in the continence mechanism after nerve sparing radical prostatectomy: a clinical and prospective study. J Urol. 2008;180(6):2527–31. Scholar
  13. Cerruto MA, D’Elia C, Siracusano S, Gedeshi X, Mariotto A, Iafrate M, et al. Systematic review and meta-analysis of non RCT’s on health related quality of life after radical cystectomy using validated questionnaires: better results with orthotopic neobladder versus ileal conduit. Eur J Surg Oncol. 2016;42(3):343–60. Scholar
  14. Chromecki TF, Cha EK, Fajkovic H, Rink M, Ehdaie B, Svatek RS, et al. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. BJU Int 2013;111(2):249–55.
  15. Clark PE, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, et al. Bladder cancer v2.2016. National Comprehensive Cancer Network treatment guidelines. 2016. Available at Accessed 10 Nov 2016.
  16. Colombo R, Pellucchi F, Moschini M, Gallina A, Bertini R, Salonia A, et al. Fifteen-year single-centre experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients. World J Urol. 2015;33(10):1389–95. Scholar
  17. Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol. 2008;179(3):873–8. Scholar
  18. Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol. 2007;178(6):2308–2312.; discussion 2313. Scholar
  19. Eisenberg MS, Thompson RH, Frank I, Kim SP, Cotter KJ, Tollefson MK, et al. Long-term renal function outcomes after radical cystectomy. J Urol. 2014;191(3):619–25. Scholar
  20. El-Bahnasawy MS, Gomha MA, Shaaban AA. Urethral pressure profile following orthotopic neobladder: differences between nerve sparing and standard radical cystectomy techniques. J Urol. 2006;175(5):1759–63. Scholar
  21. Fairey AS, Jacobsen NE, Chetner MP, Mador DR, Metcalfe JB, Moore RB, et al. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database. J Urol. 2009;182(1):85–93. Scholar
  22. Ficarra V, Dalpiaz O, Alrabi N, Novara G, Galfano A, Artibani W. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int. 2005;95(6):786–90. Scholar
  23. Fisch M, Wammack R, Müller SC, Hohenfellner R. The Mainz pouch II (sigma rectum pouch). J Urol. 1993;149(2):258–63.CrossRefPubMedGoogle Scholar
  24. Fleischmann A, Thalmann GN, Markwalder R, Studer UE. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol. 2005;23(10):2358–65. Scholar
  25. Froehner M, Brausi MA, Herr HW, Muto G, Studer UE. Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol. 2009;56(3):443–54. Scholar
  26. Furrer MA, Roth B, Kiss B, Nguyen DP, Boxler S, Burkhard FC, et al. Patients with an orthotopic low pressure bladder substitute enjoy long-term good function. J Urol. 2016a;196(4):1172–80. Scholar
  27. Furrer M, Nguyen DP, Gross T, Thalmann GN, Studer UE. Attempted nerve sparing has a long term impact on urinary continence in patients with an orthotopic bladder substitute. AUA 2016 Annual Meeting; Poster MP38-17. 2016b.Google Scholar
  28. Ganzer R, Blana A, Gaumann A, Stolzenburg JU, Rabenalt R, Bach T, et al. Topographical anatomy of periprostatic and capsular nerves: quantification and computerised planimetry. Eur Urol. 2008;54(2):353–60. Scholar
  29. Ghoneim MA, Abdel-latif M, El-mekresh M, Abol-Enein H, Mosbah A, Ashamallah A, et al. Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol. 2008;180(1):121–7. Scholar
  30. Giannarini G, Kessler TM, Thoeny HC, Nguyen DP, Meissner C, Studer UE. Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol. 2010;58(4):486–94. Scholar
  31. Gross T, Meierhans Ruf SD, Meissner C, Ochsner K, Studer UE. Orthotopic ileal bladder substitution in women: factors influencing urinary incontinence and hypercontinence. Eur Urol. 2015;68(4):664–71. Scholar
  32. Gschwend JE, Heck MM, Lehmann J, Ruebben H, Albers P, Heidenreich A, et al. Limited versus extended pelvic lymphadenectomy in patients with bladder cancer undergoing radical cystectomy: Survival results from a prospective, randomized trial (LEA AUO AB 25/02). J Clin Oncol. 2016;34. (suppl; abstr 4503)Google Scholar
  33. Hautmann RE, Volkmer BG, Schumacher MC, Gschwend JE, Studer UE. Long-term results of standard procedures in urology: the ileal neobladder. World J Urol. 2006;24(3):305–14. Scholar
  34. Hautmann RE, De Petriconi RC, Pfeiffer C, Volkmer BG. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol. 2012;61(5):1039–47. Scholar
  35. Hellenthal NJ, Hussain A, Andrews PE, Carpentier P, Castle E, Dasgupta P, et al. Surgical margin status after robot assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. J Urol. 2010;184(1):87–91. Scholar
  36. Herr HW. Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol. 2008;54(1):126–32. Scholar
  37. Herr HW, Faulkner JR, Grossman HB, Natale RB, deVere White R, Sarosdy MF, et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol. 2004;22(14):2781–9. Scholar
  38. Hugonnet CL, Danuser HJ, Springer JP, Studer UE. Urethral sensitivity and the impact on urinary continence in patients with an ileal bladder substitute after cystectomy. J Urol. 2001;165(5):1502–5.CrossRefPubMedGoogle Scholar
  39. Jensen JB, Ulhøi BP, Jensen KM. Evaluation of different lymph node (LN) variables as prognostic markers in patients undergoing radical cystectomy and extended LN dissection to the level of the inferior mesenteric artery. BJU Int. 2012a;109(3):388–93. Scholar
  40. Jensen JB, Ulhøi BP, Jensen KM. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival. Int J Urol. 2012b;19(1):39–47. Scholar
  41. Jin X, Roethlisberger S, Burkhard FC, Birkhaeuser F, Thoeny HC, Studer UE. Long-term renal function after urinary diversion by ileal conduit or orthotopic ileal bladder substitution. Eur Urol. 2012;61(3):491–7. Scholar
  42. Johar RS, Hayn MH, Stegemann AP, Ahmed K, Agarwal P, Balbay MD, et al. Complications after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol. 2013;64(1):52–7. Scholar
  43. Kaiho Y, Nakagawa H, Ikeda Y, Namiki S, Numahata K, Satoh M, et al. Intraoperative electrophysiological confirmation of urinary continence after radical prostatectomy. J Urol. 2005;173(4):1139–42. Scholar
  44. Kessler TM, Burkhard FC, Perimenis P, Danuser H, Thalmann GN, Hochreiter WW, et al. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol. 2004;172(4 Pt 1):1323–7. Scholar
  45. Khan MS, Gan C, Ahmed K, Ismail AF, Watkins J, Summers JA, et al. A single-centre early phase randomised controlled three-arm trial of open, robotic, and laparoscopic radical cystectomy (CORAL). Eur Urol. 2016;69(4):613–21. Scholar
  46. Konety BR, Dhawan V, Allareddy V, Joslyn SA. Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project. J Urol. 2005;173(5):1695–700. Scholar
  47. Kulkarni GS, Urbach DR, Austin PC, Fleshner NE, Laupacis A. Higher surgeon and hospital volume improves long-term survival after radical cystectomy. Cancer. 2013;119(19):3546–54. Scholar
  48. Larcher A, Sun M, Schiffmann J, Tian Z, Shariat SF, McCormack M, et al. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer. Eur J Surg Oncol. 2015;41(3):353–60. Scholar
  49. Madersbacher S, Hochreiter W, Burkhard F, Thalmann GN, Danuser H, Markwalder R, et al. Radical cystectomy for bladder cancer today – a homogeneous series without neoadjuvant therapy. J Clin Oncol. 2003;21(4):690–6. Scholar
  50. Mandel P, Tilki D, Eslick GD. Extent of lymph node dissection and recurrence-free survival after radical cystectomy: a meta-analysis. Urol Oncol. 2014;32(8):1184–90. Scholar
  51. Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, et al. Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol. 2012;110(6 Pt B):E222–7. Scholar
  52. Ng CK, Kauffman EC, Lee MM, Otto BJ, Portnoff A, Ehrlich JR, et al. A comparison of postoperative complications in open versus robotic cystectomy. Eur Urol. 2010;57(2):274–81. Scholar
  53. Nguyen DP, Al Hussein Al Awamlh B, Wu X, O’Malley P, Inoyatov IM, Ayangbesan A, et al. Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer. Eur Urol. 2015;68(3):399–405. Scholar
  54. Nieuwenhuijzen JA, De Vries RR, Bex A, van der Poel HG, Meinhardt W, Antonini N, et al. Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions. Eur Urol. 2008;53(4):834–44. Scholar
  55. Novara G, De Marco V, Aragona M, Boscolo-Berto R, Cavalleri S, Artibani W, et al. Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol. 2009;182(3):914–21. Scholar
  56. Novara G, Svatek RS, Karakiewicz PI, Skinner E, Ficarra V, Fradet Y, et al. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol. 2010;183(6):2165–70. Scholar
  57. Ong CH, Schmitt M, Thalmann GN, Studer UE. Individualized seminal vesicle sparing cystoprostatectomy combined with ileal orthotopic bladder substitution achieves good functional results. J Urol. 2010;183(4):1337–42. Scholar
  58. Ost MC, Patel KP, Rastinehad AR, Chu PY, Anderson AE, Smith AD, et al. Pneumoperitoneum with carbon dioxide inhibits macrophage tumor necrosis factor-alpha secretion: source of transitional-cell carcinoma port-site metastasis, with prophylactic irrigation strategies to decrease laparoscopic oncologic risks. J Endourol. 2008;22(1):105–12. Scholar
  59. Paananen I, Ohtonen P, Perttilä I, Jonsson O, Edlund C, Wiklund P, et al. Functional results after orthotopic bladder substitution: a prospective multicentre study comparing four types of neobladder. Scand J Urol. 2014;48(1):90–8.CrossRefPubMedGoogle Scholar
  60. Pfitzenmaier J, Lotz J, Faldum A, Beringer M, Stein R, Thüroff JW. Metabolic evaluation of 94 patients 5 to 16 years after ileocecal pouch (Mainz pouch 1) continent urinary diversion. J Urol. 2003;170(5):1884–7. Scholar
  61. Ploussard G, Shariat SF, Dragomir A, Kluth LA, Xylinas E, Masson-Lecomte A, et al. Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time. Eur Urol. 2014;66(2):361–70. Scholar
  62. Raza SJ, Wilson T, Peabody JO, Wiklund P, Scherr DS, Al-Daghmin A, et al. Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol. 2015;68(4):721–8. Scholar
  63. Roth B, Wissmeyer MP, Zehnder P, Birkhäuser FD, Thalmann GN, Krause TM, et al. A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol. 2010;57(2):205–11. Scholar
  64. Rozanski AT, Benson CR, McCoy JA, Green C, Grossman HB, et al. Is exam under anesthesia still necessary for the staging of bladder cancer in the era of modern imaging? Bladder Cancer. 2015;1(1):91–6.CrossRefGoogle Scholar
  65. Shabsigh A, Korets R, Vora KC, Brooks CM, Cronin AM, Savage C, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55(1):164–74. Scholar
  66. Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006;176(6 Pt 1):2414–22.
  67. Sievert K, Hennenlotter J, Laible I, Amend B, Schilling D, Anastasiadis A, et al. The periprostatic autonomic nerves-bundle or layer? Eur Urol. 2008;54(5):1109–17. Scholar
  68. Simone G, Papalia R, Ferriero M, Guaglianone S, Castelli E, Collura D, et al. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. Int J Urol. 2013;20(4):390–7. Scholar
  69. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19(3):666–75.CrossRefPubMedGoogle Scholar
  70. Studer UE, editor. Keys to successful orthotopic bladder substitution: Springer International Publishing; 2015.
  71. Svatek RS, Fisher MB, Matin SF, Kamat AM, Grossman HB, Nogueras-González GM, et al. Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria. J Urol. 2010;183(3):929–34. Scholar
  72. Svatek RS, Shariat SF, Novara G, Skinner EC, Fradet Y, Bastian PJ, et al. Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort. BJU Int. 2011;107(6):898–904. Scholar
  73. Takenaka A, Tewari A, Hara R, Leung RA, Kurokawa K, Murakami G, et al. Pelvic autonomic nerve mapping around the prostate by intraoperative electrical stimulation with simultaneous measurement of intracavernous and intraurethral pressure. J Urol. 2007;177(1):225–9. Scholar
  74. Tarin TV, Power NE, Ehdaie B, Sfakianos JP, Silberstein JL, Savage CJ, et al. Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity. Eur Urol. 2012;61(5):1025–30. Scholar
  75. Turner WH, Danuser H, Moehrle K, Studer UE. The effect of nerve sparing cystectomy technique on postoperative continence after orthotopic bladder substitution. J Urol. 1997;158(6):2118–22.CrossRefPubMedGoogle Scholar
  76. Vallancien G, Abou El Fettouh H, Cathelineau X, Baumert H, Fromont G, Guillonneau B. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. J Urol. 2002;168(6):2413–7. Scholar
  77. Wang GJ, Barocas DA, Raman JD, Scherr DS. Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy. BJU Int. 2008;101(1):89–93. Scholar
  78. Yafi FA, Aprikian AG, Chin JL, Fradet Y, Izawa J, Estey E, et al. Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre. BJU Int 2011;108(4):539–45.
  79. Yuh B, Wilson T, Bochner B, et al. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy. Eur Urol. 2015;67:402–22. Scholar
  80. Zehnder P, Studer UE, Skinner EC, et al. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol. 2011;186:1261–8. Scholar
  81. Zehnder P, Studer UE, Skinner EC, et al. Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades. BJU Int. 2013;112:E51–8. Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of UrologyBern University HospitalBernSwitzerland

Section editors and affiliations

  • Wolfgang Otto
    • 1
  • Shahrokh F. Shariat
    • 2
  1. 1.der Universität RegensburgOberarzt der Klinik für UrologieRegensburgGermany
  2. 2.Departement of UrologyWeill Cornell Medical CenterNew YorkUSA

Personalised recommendations